ICUI icon

ICU Medical

136.72 USD
-1.95
1.41%
At close Apr 21, 4:00 PM EDT
After hours
136.72
+0.00
0.00%
1 day
-1.41%
5 days
-5.68%
1 month
-7.04%
3 months
-18.07%
6 months
-23.59%
Year to date
-13.46%
1 year
41.86%
5 years
-36.57%
10 years
54.63%
 

About: ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Employees: 15,000

0
Funds holding %
of 7,419 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

85% more call options, than puts

Call options by funds: $10.7M | Put options by funds: $5.79M

5% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 95

5% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 39

0.63% less ownership

Funds ownership: 99.15% [Q3] → 98.52% (-0.63%) [Q4]

1% less funds holding

Funds holding: 286 [Q3] → 283 (-3) [Q4]

15% less capital invested

Capital invested by funds: $4.41B [Q3] → $3.74B (-$665M) [Q4]

100% less funds holding in top 10

Funds holding in top 10: 4 [Q3] → 0 (-4) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$191
40%
upside
Avg. target
$191
40%
upside
High target
$191
40%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Keybanc
Tim Rezvan
15% 1-year accuracy
7 / 46 met price target
40%upside
$191
Overweight
Maintained
21 Apr 2025

Financial journalist opinion

Based on 4 articles about ICUI published over the past 30 days

Negative
Zacks Investment Research
1 week ago
ICUI Stock Declines Despite Plans for Offsetting Tariff Impacts
ICU Medical unveils a strategic plan to offset new U.S. tariffs, aiming to protect margins and stability amid medtech market volatility and global trade shifts.
ICUI Stock Declines Despite Plans for Offsetting Tariff Impacts
Positive
Zacks Investment Research
1 week ago
ICUI Stock Gains Following Latest FDA Approvals for Precision IV Pumps
ICU Medical aims to enable healthcare systems to customize infusion setups, optimizing device footprint without compromising performance or safety.
ICUI Stock Gains Following Latest FDA Approvals for Precision IV Pumps
Neutral
PRNewsWire
2 weeks ago
ICU Medical Introduces Its New Category of Infusion Devices With FDA Clearances of Plum Solo™ and Plum Duo™ Precision IV Pumps
New devices address infusion delivery variability and expand the ICU Medical IV Performance Platform. SAN CLEMENTE, Calif.
ICU Medical Introduces Its New Category of Infusion Devices With FDA Clearances of Plum Solo™ and Plum Duo™ Precision IV Pumps
Neutral
GlobeNewsWire
4 weeks ago
ICU Medical to Present at the 24th Annual Needham Virtual Healthcare Conference
SAN CLEMENTE, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 24th Annual Needham Virtual Healthcare Conference being held April 7-10, 2025. ICU Medical's presentation will be on Monday, April 7, 2025 at 8:00 a.m. PT (11:00 a.m. ET). Company management will also be participating in one-on-one meetings on Monday, April 7, 2025.
ICU Medical to Present at the 24th Annual Needham Virtual Healthcare Conference
Neutral
GlobeNewsWire
1 month ago
ICU Medical to Participate at the KeyBanc Healthcare Forum
SAN CLEMENTE, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the KeyBanc Healthcare Forum being held virtually, March 18-19, 2025. ICU Medical's fireside chat will be on Wednesday, March 19, 2025 at 8:15 a.m. PT (11:15 a.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, March 19, 2025.
ICU Medical to Participate at the KeyBanc Healthcare Forum
Neutral
Seeking Alpha
1 month ago
ICU Medical, Inc. (ICUI) Q4 2024 Earnings Call Transcript
ICU Medical, Inc. (NASDAQ:ICUI ) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants John Mills - ICR, IR Vivek Jain - Chairman and CEO Brian Bonnell - Chief Financial Officer Conference Call Participants Jayson Bedford - Raymond James Brett Fishbin - KeyBanc Capital Markets Charlie Strauzer - CJS Securities Michael Toomey - Jefferies Joseph Conway - Needham Operator Good day. And welcome to the ICU Medical, Inc. Fourth Quarter 2024 Earnings Conference Call.
ICU Medical, Inc. (ICUI) Q4 2024 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
ICU Medical (ICUI) Q4 Earnings and Revenues Top Estimates
ICU Medical (ICUI) came out with quarterly earnings of $2.11 per share, beating the Zacks Consensus Estimate of $1.48 per share. This compares to earnings of $1.57 per share a year ago.
ICU Medical (ICUI) Q4 Earnings and Revenues Top Estimates
Neutral
GlobeNewsWire
1 month ago
ICU Medical Announces Fourth Quarter 2024 Results and Provides Fiscal Year 2025 Guidance
SAN CLEMENTE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended December 31, 2024.
ICU Medical Announces Fourth Quarter 2024 Results and Provides Fiscal Year 2025 Guidance
Neutral
GlobeNewsWire
2 months ago
ICU Medical to Present at the Raymond James 46th Annual Institutional Investors Conference
SAN CLEMENTE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 46th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-5, 2025. ICU Medical's presentation will be on Monday, March 3, 2025 at 5:40 a.m. PT (8:40 a.m. ET). Company management will also be participating in one-on-one meetings on Monday, March 3, 2025.
ICU Medical to Present at the Raymond James 46th Annual Institutional Investors Conference
Neutral
GlobeNewsWire
2 months ago
ICU Medical Announces Time of Fourth Quarter 2024 Earnings Conference Call
SAN CLEMENTE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2024 earnings release and conference call.
ICU Medical Announces Time of Fourth Quarter 2024 Earnings Conference Call
Charts implemented using Lightweight Charts™